ALKERAN DIN 00004715
Health Canada record
| Active ingredient(s) | MELPHALAN 2 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01AA03 MELPHALAN |
| Original market date | 31-Dec-1964 |
| Current status date | 26-Apr-2018 |
| Source | Health Canada DPD |
Establishment licence of the holder
Aspen Pharmacare Canada Inc. — licence 3-002349, currently licensed, last inspection rating C (2026-03-12).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 19003 | 2017-02-23 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBERS |
| 16562 | 2015-01-23 | New Drug Submission (NDS) | TRANSFER OF DRUG IDENTIFICATION NUMBERS |
| 16376 | 2014-11-28 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
| 11915 | 2010-12-08 | New Drug Submission (NDS) | Manufacturer name change |
| 2414 | 2001-08-28 | New Drug Submission (NDS) | CHANGE IN MANUFACTURER NAME |
International API supply for MELPHALAN
2 valid EDQM Certificates of Suitability from 2 holders. 13 active FDA Drug Master Files.
Request a quote for ALKERAN